Abstract:Objective: Most pancreatic tumors are epithelial, and, among these, more than 90% are of ductal origin. However, a variety of mesenchymal tumors may involve the pancreas and may manifest different clinicopathological characteristics. The literature on mesenchymal tumors in the pancreas is largely limited to individual case reports or analyses of small series, predominantly focusing on radiologic features.
Material and Method:Authors' institutional and consultation databases were reviewed to identify the mesenc… Show more
“…Even though primary mesenchymal tumors of the pancreas are rare, various mesenchymal tumor types arising from pancreatic stromal tissue have been reported, including inflammatory myofibroblastic tumor, desmoid tumor, GIST, lymphangioma, cavernous hemangioma, angiomyolipoma, schwannoma, ganglioneuroma, leiomyosarcoma, rhabdomyosarcoma, liposarcoma, angiosarcoma, Ewing sarcoma/ primitive neuroectodermal tumor, undifferentiated/unclassified sarcoma. 28,34,50 However, experience with SFT is very limited. Our current understanding of this tumor is mainly based on individual case reports.…”
Solitary fibrous tumor (SFT) has been increasingly reported in various anatomic sites. However, it is still extremely rare in the pancreas. Herein, we present the first series of primary pancreatic SFTs. Nine cases of primary pancreatic SFTs were analyzed. The mean age was 60 years (36 to 76 y) with no sex predilection. Six tumors were in the head, 3 were in the tail. On imaging studies, tumors were described as a hypervascular mass, 2 revealed cystic areas, and 3 were favored to be neuroendocrine tumors. On biopsy, 2 cases were diagnosed as atypical spindle cell tumor; one was misdiagnosed as suspicious for sarcoma, and another case as metastatic renal cell carcinoma. Two were diagnosed as low-grade sarcoma and low-grade stromal tumor on frozen sections. Grossly, tumors were well-demarcated with a median size of 4 cm (0.9 to 15 cm). Microscopically, they were composed of ovoid to spindle tumor cells with no significant mitotic activity and were arranged in alternating hypercellular and hypocellular areas. Staghorn-like vessels and entrapped pancreatic parenchyma were also detected within all tumors. Tumor cells revealed diffuse/strong nuclear STAT6 expression in 7 of 8, CD34 in 7 of 9, and bcl-2 in 4 of 4 tested cases. One tested tumor harbored NAB2-STAT6 fusion. Eight patients with available follow-up data were free of disease at a mean follow-up of 76 months (3 to 189 mo). SFT should be considered in the differential diagnoses of mesenchymal neoplasms of the pancreas. Immunohistochemical nuclear STAT6 expression is a characteristic feature of SFT. Primary pancreatic SFTs seem to have favorable biological behavior in our series.
“…Even though primary mesenchymal tumors of the pancreas are rare, various mesenchymal tumor types arising from pancreatic stromal tissue have been reported, including inflammatory myofibroblastic tumor, desmoid tumor, GIST, lymphangioma, cavernous hemangioma, angiomyolipoma, schwannoma, ganglioneuroma, leiomyosarcoma, rhabdomyosarcoma, liposarcoma, angiosarcoma, Ewing sarcoma/ primitive neuroectodermal tumor, undifferentiated/unclassified sarcoma. 28,34,50 However, experience with SFT is very limited. Our current understanding of this tumor is mainly based on individual case reports.…”
Solitary fibrous tumor (SFT) has been increasingly reported in various anatomic sites. However, it is still extremely rare in the pancreas. Herein, we present the first series of primary pancreatic SFTs. Nine cases of primary pancreatic SFTs were analyzed. The mean age was 60 years (36 to 76 y) with no sex predilection. Six tumors were in the head, 3 were in the tail. On imaging studies, tumors were described as a hypervascular mass, 2 revealed cystic areas, and 3 were favored to be neuroendocrine tumors. On biopsy, 2 cases were diagnosed as atypical spindle cell tumor; one was misdiagnosed as suspicious for sarcoma, and another case as metastatic renal cell carcinoma. Two were diagnosed as low-grade sarcoma and low-grade stromal tumor on frozen sections. Grossly, tumors were well-demarcated with a median size of 4 cm (0.9 to 15 cm). Microscopically, they were composed of ovoid to spindle tumor cells with no significant mitotic activity and were arranged in alternating hypercellular and hypocellular areas. Staghorn-like vessels and entrapped pancreatic parenchyma were also detected within all tumors. Tumor cells revealed diffuse/strong nuclear STAT6 expression in 7 of 8, CD34 in 7 of 9, and bcl-2 in 4 of 4 tested cases. One tested tumor harbored NAB2-STAT6 fusion. Eight patients with available follow-up data were free of disease at a mean follow-up of 76 months (3 to 189 mo). SFT should be considered in the differential diagnoses of mesenchymal neoplasms of the pancreas. Immunohistochemical nuclear STAT6 expression is a characteristic feature of SFT. Primary pancreatic SFTs seem to have favorable biological behavior in our series.
“…Most pancreatic tumors are of epithelial origin, with more than 90% being pancreatic ductal adenocarcinomas[ 3 ]. However, tumors of mesenchymal origin can also involve the pancreas, accounting for 1%-2% of all tumors[ 3 ].…”
Section: Discussionmentioning
confidence: 99%
“…Most pancreatic tumors are of epithelial origin, with more than 90% being pancreatic ductal adenocarcinomas[ 3 ]. However, tumors of mesenchymal origin can also involve the pancreas, accounting for 1%-2% of all tumors[ 3 ]. Mesenchymal tumors can be derived from the connective, lymphatic, neuronal, and vascular tissues, and show different clinicopathologic manifestations and outcomes[ 3 ].…”
Section: Discussionmentioning
confidence: 99%
“…However, tumors of mesenchymal origin can also involve the pancreas, accounting for 1%-2% of all tumors[ 3 ]. Mesenchymal tumors can be derived from the connective, lymphatic, neuronal, and vascular tissues, and show different clinicopathologic manifestations and outcomes[ 3 ]. Primary mesenchymal tumors of the pancreas that are known to show benign or borderline behavior include schwannomas, inflammatory myofibroblastic tumors, hamartomas, and solitary fibrous tumors in order of frequency[ 4 ].…”
Section: Discussionmentioning
confidence: 99%
“…SFT is mostly found in the pleura but can also occur in non-pleural sites[ 2 ]. The pancreas is an extremely rare non-pleural localization for SFT, with the majority of the tumors being secondary lesions[ 3 , 4 ]. According to the case report Yamashita et al [ 5 ] published in 2019, 21 cases of primary and secondary SFTs of the pancreas were reported in the English literature.…”
BACKGROUND
Solitary fibrous tumor (SFT) is a rare mesenchymal tumor that is most commonly found in the pleura but can also originate from non-pleural sites. Among the non-pleural localizations, the pancreas is extremely rare. In particular, metastasis to the pancreas from the central nervous system (CNS) is extremely rare, with only two cases reported so far. We report a case of recurrence in the pancreas 14 years after the initial complete surgical removal of a tumor in the CNS.
CASE SUMMARY
A 68-year-old man with a past medical history of recurrent meningeal hemangiopericytoma, currently referred to as SFT, presented to the hospital with jaundice. The patient was first diagnosed with an 8cm-sized meningeal hemangiopericytoma fourteen years ago and underwent osteoplastic craniotomy. After 16 mo, imaging showed recurrence and he underwent gamma knife radiosurgery (GKRS). 2 years later, imaging showed recurrence again leading to a second GKRS. 5 years later, recurrence was again suspected leading to a second craniotomy. Since then 3 years had passed, and imaging showed a 3.5cm-sized mass lesion on the pancreatic head with obstruction of the pancreatic and bile ducts. Endosonography with fine-needle aspiration biopsy was done preoperatively and aided in the diagnosis of SFT. The patient underwent pylorus-preserving pancreaticoduodenectomy. Pathologic findings of the resected pancreatic specimen, consistent with the previously resected brain specimen, confirmed the diagnosis of SFT.
CONCLUSION
The rarity and lack of knowledge about SFTs make suspecting and diagnosing this disease challenging. We believe that a report of metastatic pancreatic SFT from the CNS will contribute to a better understanding of this rare disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.